UK MHRA completes inspection at Lupin’s Pithampur facilities

09 May 2020 Evaluate

The Medicines and Healthcare products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK) has successfully completed inspection at Lupin’s three manufacturing units in Pithampur (India). The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020. The successful close out of the inspection at Pithampur, and release of the inspection report by UK MHRA further bolsters company’s confidence in its quality standards and manufacturing processes.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally

Lupin Share Price

2119.00 5.85 (0.28%)
18-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.00
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 910.00
Lupin 2119.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×